NEW YORK: FD Morgen-Walke (FDMW) has formed a global life-sciences practice that will coordinate the efforts of account executives in its Boston, San Francisco, and New York offices. The team's coverage areas will include pharmaceuticals, medical devices, diagnostics, drug discovery, women's healthcare, and bioscience venture capital.
The group's current clients include GlaxoSmithKline, Amersham, Smith & Nephew, Shire Pharmaceuticals, Alcon Laboratories, and Watson Pharmaceuticals.
SVP Leslie Wolf-Creutzfeldt will lead the new Life Sciences practice.
Although the agency is primarily known for its work in ...